Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
dobutamine 12,5 mg/mL, flacon de 20 mL d'un concentré pour perfusion |
Is a |
False |
Dobutamine hydrochloride |
Inferred relationship |
Some |
|
dobutamine 50 mg/mL, ampoule de 5 mL de concentré pour perfusion |
Is a |
False |
Dobutamine hydrochloride |
Inferred relationship |
Some |
|
dobutamine 12,5 mg/mL, flacon de 20 mL d'un concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dobutamine hydrochloride |
Inferred relationship |
Some |
|
dobutamine 50 mg/mL, ampoule de 5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dobutamine hydrochloride |
Inferred relationship |
Some |
|
Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dobutamine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely dobutamine (as dobutamine hydrochloride) 250 milligram/20 milliliter conventional release solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 250 milligram/5 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 50 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |
Dobutamine (as dobutamine hydrochloride) 50 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dobutamine hydrochloride |
Inferred relationship |
Some |
1 |